MARS1
Methionine--tRNA ligase, cytoplasmic
Also known as: CMT2U, MARS, MetRS, SPG70, SYMC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56192
- Gene
- MARS1
- Ensembl
- ENSG00000166986
- Chromosome
- 12
- Canonical length
- 900 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol,Mid piece,Principal piece,End piece
OverviewNCBI Gene
This gene encodes a member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. The encoded protein is a component of the multi-tRNA synthetase complex and catalyzes the ligation of methionine to tRNA molecules. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
900 residues, UniProt reviewed canonical sequence.
>P56192|MARS1
1 MRLFVSDGVP GCLPVLAAAG RARGRAEVLI STVGPEDCVV PFLTRPKVPV LQLDSGNYLF
61 STSAICRYFF LLSGWEQDDL TNQWLEWEAT ELQPALSAAL YYLVVQGKKG EDVLGSVRRA
121 LTHIDHSLSR QNCPFLAGET ESLADIVLWG ALYPLLQDPA YLPEELSALH SWFQTLSTQE
181 PCQRAAETVL KQQGVLALRP YLQKQPQPSP AEGRAVTNEP EEEELATLSE EEIAMAVTAW
241 EKGLESLPPL RPQQNPVLPV AGERNVLITS ALPYVNNVPH LGNIIGCVLS ADVFARYSRL
301 RQWNTLYLCG TDEYGTATET KALEEGLTPQ EICDKYHIIH ADIYRWFNIS FDIFGRTTTP
361 QQTKITQDIF QQLLKRGFVL QDTVEQLRCE HCARFLADRF VEGVCPFCGY EEARGDQCDK
421 CGKLINAVEL KKPQCKVCRS CPVVQSSQHL FLDLPKLEKR LEEWLGRTLP GSDWTPNAQF
481 ITRSWLRDGL KPRCITRDLK WGTPVPLEGF EDKVFYVWFD ATIGYLSITA NYTDQWERWW
541 KNPEQVDLYQ FMAKDNVPFH SLVFPCSALG AEDNYTLVSH LIATEYLNYE DGKFSKSRGV
601 GVFGDMAQDT GIPADIWRFY LLYIRPEGQD SAFSWTDLLL KNNSELLNNL GNFINRAGMF
661 VSKFFGGYVP EMVLTPDDQR LLAHVTLELQ HYHQLLEKVR IRDALRSILT ISRHGNQYIQ
721 VNEPWKRIKG SEADRQRAGT VTGLAVNIAA LLSVMLQPYM PTVSATIQAQ LQLPPPACSI
781 LLTNFLCTLP AGHQIGTVSP LFQKLENDQI ESLRQRFGGG QAKTSPKPAV VETVTTAKPQ
841 QIQALMDEVT KQGNIVRELK AQKADKNEVA AEVAKLLDLK KQLAVAEGKP PEAPKGKKKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MARS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 65 nTPM
- pituitary gland: 57 nTPM
- liver: 57 nTPM
- esophagus: 53 nTPM
- spleen: 53 nTPM
- cerebral cortex: 52 nTPM
Single-cell type
- epicardial cells: 409 nCPM
- cardiomyocytes: 250 nCPM
- neutrophils: 196 nCPM
- plasma cells: 94 nCPM
- pdcs: 86 nCPM
- thymocytes: 75 nCPM
Immune cell
- myeloid DC: 58 nTPM
- plasmacytoid DC: 56 nTPM
- intermediate monocyte: 54 nTPM
- non-classical monocyte: 46 nTPM
- eosinophil: 39 nTPM
- gdT-cell: 35 nTPM
Brain region
- pons: 53 nTPM
- hypothalamus: 51 nTPM
- hippocampal formation: 50 nTPM
- cerebral cortex: 49 nTPM
- white matter: 49 nTPM
- midbrain: 48 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MARS1.
Disease | AllUniProt
Conditions MARS1 is implicated in, by any mechanism.
- Interstitial lung and liver disease (ILLD) MIM:615486
- Charcot-Marie-Tooth disease, axonal, type 2U (CMT2U) MIM:616280
- Trichothiodystrophy 9, non-photosensitive (TTD9) MIM:619692
- Spastic paraplegia 70, autosomal recessive (SPG70) MIM:620323
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 950 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency
- Autosomal recessive spastic paraplegia type 70
- Pulmonary alveolar proteinosis
- Charcot-Marie-Tooth disease axonal type 2U
- Germ cell tumor of testis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- DepMap mean gene effect
- -1.69
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to epidermal growth factor stimulus
- cellular response to platelet-derived growth factor stimulus
- methionyl-tRNA aminoacylation
- positive regulation of transcription of nucleolar large rRNA by RNA polymerase I
- rRNA transcription
- tRNA aminoacylation for protein translation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WHEP-TRS domain
- Aminoacyl-tRNA synthetase, class I, conserved site
- Glutathione S-transferase, C-terminal
- uS15/NS1, RNA-binding domain superfamily
- Aminoacyl-tRNA synthetase, class Ia, anticodon-binding
- Glutathione S-transferase, C-terminal-like
- Rossmann-like alpha/beta/alpha sandwich fold
- Methionyl-tRNA synthetase
- Methionyl/Leucyl tRNA synthetase
- Methioninyl-tRNA synthetase core domain
- Glutathione S-transferase, C-terminal domain superfamily
- Methionyl-tRNA synthetase, anticodon-binding domain
- Glutathione S-transferase, C-terminal domain
- WHEP-TRS domain
- tRNA synthetases class I (M)
- Anticodon binding domain of methionyl tRNA ligase
- Methionine-tRNA ligase, type 1
- Methionyl-tRNA synthetase, Zn-domain
- Methionine--tRNA ligase, N-terminal
- Glutathione S-transferase, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MARS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MARS1 as an antibody target. Whether an autoantibody or antibody against MARS1 could matter depends on whether native MARS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MARS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MARS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...